Type 8 long QT syndrome: pathogenic variants in CACNA1C-encoded Cav1.2 cluster in STAC protein binding site.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 Nov 2019
Historique:
received: 12 03 2019
accepted: 18 07 2019
pubmed: 14 8 2019
medline: 26 11 2020
entrez: 14 8 2019
Statut: ppublish

Résumé

Pathogenic gain-of-function variants in CACAN1C cause type-8 long QT syndrome (LQT8). We sought to describe the electrocardiographic features in LQT8 and utilize molecular modelling to gain mechanistic insights into its genetic culprits. Rare variants in CACNA1C were identified from genetic testing laboratories. Treating physicians provided clinical information. Variant pathogenicity was independently assessed according to recent guidelines. Pathogenic (P) and likely pathogenic (LP) variants were mapped onto a 3D modelled structure of the Cav1.2 protein. Nine P/LP variants, identified in 23 patients from 19 families with non-syndromic LQTS were identified. Six variants, found in 79% of families, clustered to a 4-residue section in the cytosolic II-III loop region which forms a region capable of binding STAC SH3 domains. Therefore, variants may affect binding of SH3-domain containing proteins. Arrhythmic events occurred in similar proportions of patients with II-III loop variants and with other P/LP variants (53% vs. 48%, P = 0.41) despite shorter QTc intervals (477 ± 31 ms vs. 515 ± 37 ms, P = 0.03). A history of sudden death was reported only in families with II-III loop variants (60% vs. 0%, P = 0.03). The predominant T-wave morphology was a late peaking T wave with a steep descending limb. Exercise testing demonstrated QTc prolongation on standing and at 4 min recovery after exercise. The majority of P/LP variants in patients with CACNA1C-mediated LQT8 cluster in an SH3-binding domain of the cytosolic II-III loop. This represents a 'mutation hotspot' in LQT8. A late-peaking T wave with a steep descending limb and QT prolongation on exercise are commonly seen.

Identifiants

pubmed: 31408100
pii: 5549425
doi: 10.1093/europace/euz215
doi:

Substances chimiques

CACNA1C protein, human 0
Calcium Channels, L-Type 0
DNA 9007-49-2

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1725-1732

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Greg J Mellor (GJ)

Division of Cardiology, University of British Columbia, 1033 Davie St., Rm 211, Vancouver, BC, Canada.
Cardiology Department, Royal Papworth Hospital, Cambridge, UK.

Pankaj Panwar (P)

Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada.

Andrea K Lee (AK)

Division of Cardiology, University of British Columbia, 1033 Davie St., Rm 211, Vancouver, BC, Canada.

Christian Steinberg (C)

Division of Cardiology, University of British Columbia, 1033 Davie St., Rm 211, Vancouver, BC, Canada.

Julie A Hathaway (JA)

Division of Cardiology, University of British Columbia, 1033 Davie St., Rm 211, Vancouver, BC, Canada.

Kirsten Bartels (K)

Division of Cardiology, University of British Columbia, 1033 Davie St., Rm 211, Vancouver, BC, Canada.

Susan Christian (S)

Department of Medical Genetics, University of Alberta, Edmonton, AB, Canada.

Seshadri Balaji (S)

Division of Cardiology, Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA.

Jason D Roberts (JD)

Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, ON, Canada.

Chris S Simpson (CS)

Heart Rhythm Service, Division of Cardiology, Queen's University, Kingston, ON, Canada.

Nicole J Boczek (NJ)

Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Division of Pediatric Cardiology, Department of Pediatrics, Mayo Clinic, Rochester, MN, USA.
Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.

David J Tester (DJ)

Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Division of Pediatric Cardiology, Department of Pediatrics, Mayo Clinic, Rochester, MN, USA.
Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.

Andrew E Radbill (AE)

Vanderbilt University Medical Center, Nashville, TN, USA.

Ngai-Shing Mok (NS)

Department of Medicine & Geriatrics, Princess Margaret Hospital, Kowloon, Hong Kong.

Robert M Hamilton (RM)

Labatt Family Heart Centre and Division of Cardiology, Department of Pediatrics, and Translational Medicine, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.

Elizabeth S Kaufman (ES)

MetroHealth Campus, Case Western Reserve University, Cleveland, OH, USA.

Paul L Eugenio (PL)

Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.

Raul Weiss (R)

Wexner Medical Center, The Ohio State University, Columbus, OH, USA.

Craig January (C)

School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.

George M McDaniel (GM)

Division of Pediatric Cardiology, University of Virginia, Charlottesville, VA, USA.

Richard A Leather (RA)

Royal Jubilee Hospital, Victoria, BC, Canada.

Christopher Erickson (C)

Pediatric Cardiology, Children's Hospital & Medical Center/University of Nebraska Medical Center, Omaha, NA, USA.

Shelley Falik (S)

Division of Cardiology, Department of Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA.

Elijah R Behr (ER)

Cardiology Clinical Academic Group, St. George's, University of London, London, UK.

Arthur A M Wilde (AAM)

Heart Centre, Department of Clinical and Experimental Cardiology, Academic Medical Centre, Amsterdam, the Netherlands.

Shubhayan Sanatani (S)

Children's Heart Center, BC Children's Hospital, Vancouver, BC, Canada.

Michael J Ackerman (MJ)

Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Division of Pediatric Cardiology, Department of Pediatrics, Mayo Clinic, Rochester, MN, USA.
Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.

Filip Van Petegem (F)

Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada.

Andrew D Krahn (AD)

Division of Cardiology, University of British Columbia, 1033 Davie St., Rm 211, Vancouver, BC, Canada.

Zachary Laksman (Z)

Division of Cardiology, University of British Columbia, 1033 Davie St., Rm 211, Vancouver, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH